Fusion protein for promoting endothelial repair and preparation method and application thereof

A technology of fusion protein and endothelium, applied in the field of genetic engineering, can solve the problems of lack of specificity of implants, delayed endothelialization, etc., and achieve the effects of increasing endothelial inflammation, accelerating endothelialization, and simple preparation method.

Active Publication Date: 2021-06-18
CHONGQING UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, vascular tissue engineering implants are not specific. While inhibiting smooth muscle or abnormal intimal hyperplasia, most of them also inhibit the biological behavior and function of endothelial cells and delay endothelialization.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fusion protein for promoting endothelial repair and preparation method and application thereof
  • Fusion protein for promoting endothelial repair and preparation method and application thereof
  • Fusion protein for promoting endothelial repair and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Construction of embodiment 1 fusion protein expression plasmid

[0050] The present invention utilizes Trizol (Takara Company) to extract total RNA from human umbilical vein endothelial cells (HUVECs), and then uses a reverse transcription kit to reverse the RNA into cDNA. The desired VE-cadherin (EC1-2) fragment is obtained through PCR reaction amplification with specific primers. Due to the difficult source of Mfp-5, the desired Mfp-5 fragment was obtained by chemical synthesis. 15 homologous bases were added at the junction of VE-cadherin (EC1-2) and Mfp-5 sequences, so that VE-cadherin (EC1-2) and Mfp-5 sequences were fused together by In-fusion recombinase, Then cloned into the vector PET32a by T4 ligase, see figure 1 Schematic diagram of fusion protein expression plasmid.

Embodiment 2

[0051] Expression and purification of embodiment 2 fusion protein

[0052] After the construction of the expression plasmid is completed, the plasmid is introduced into Escherichia coli DE3 (BL21) cells, and according to the amount of required protein, an appropriate amount of Escherichia coli cells containing the target gene expression vector is cultivated to an OD600 of 0.6-0.8, and 0.05mM IPTG is added Induce the expression of the fusion protein at 28°C for 5-8 hours, collect the bacteria by centrifugation at 8000rpm for 20min at 4°C, then sonicate the E. coli cells in an ice bath with a sonicator, collect the supernatant by centrifugation, filter at 0.45um, and pass through His with a nickel column Tags were used to extract and purify the fusion protein, and the resulting protein was dialyzed on ice and stored in 1% HAc. The concentration of the fusion protein was determined by the BCA method and identified by immunoblotting. For the purification of the fusion protein, see...

Embodiment 3

[0053] Embodiment 3 Adhesion experiment of fusion protein and substrate

[0054] The present invention locates the fusion protein by combining FITC fluorescent molecules, and measures the adhesion and coating conditions of the fusion protein on three different substrates of 316L stainless steel, PLCL, and TC-PS. In this test, the fusion protein solution is added to Place in 24-well plates with different substrates, incubate at room temperature for 24 hours, take pictures with a fluorescence microscope after ultrasonic cleaning, and characterize the fusion protein coating with an atomic force microscope and a water contact angle meter. At the same time, the adhesion of the fusion protein on the gold sheet was observed in real time by the SPR instrument.

[0055] After soaking, all three kinds of substrates have obvious and uniform fluorescent coatings, which shows that the fusion protein constructed and expressed by the present invention has good adhesion ability to solid subst...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of genetic engineering, and in particular relates to a fusion protein for promoting endothelial repair and its preparation method and application. The amino acid sequence of the fusion protein promoting endothelial repair of the present invention is shown in SEQ ID NO.1. The fusion protein for promoting endothelial repair provided by the present invention can efficiently and specifically promote the adhesion of endothelial cells and endothelial progenitor cells, can promote the proliferation of endothelial cells, and will not increase the adhesion of smooth muscle cells and endothelial inflammation, and is beneficial to endothelial cells. Cellular tight junctions and NO release, thereby accelerating endothelialization of blood vessels. The fusion protein or its prepared recombinant carrier can be used in the preparation of biomaterials promoting endothelial repair, and has important clinical significance.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and in particular relates to a fusion protein for promoting endothelial repair and its preparation method and application. Background technique [0002] Cardiovascular implant materials are closely related to the treatment of human diseases and the quality of life. At present, the commonly used clinical cardiovascular implant materials mainly include artificial blood vessels and vascular stents. Due to the lack of tissue regeneration ability, artificial blood vessels are prone to thrombosis, hyperplasia and calcification; vascular implant materials, mainly intravascular stents, are in direct contact with blood and vessel wall tissue in the body, and cause mechanical damage to the implanted site. Thrombosis and subsequent restenosis are major clinical problems. These problems mainly stem from the surface properties of the implant material. Therefore, clinical applications put forwar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/70A61L31/10A61L31/16A61L27/50A61L27/54A61L27/34A61K38/17A61P43/00
CPCA61K38/00A61K38/17A61K38/1709A61L27/34A61L27/507A61L27/54A61L31/10A61L31/16A61L2300/252A61L2300/414A61L2300/606C07K14/43504C07K14/70525C07K2319/00C12N15/70C08L89/00A61K2300/00
Inventor 黄俊丽杨东川王贵学邱菊辉赵银瓶
Owner CHONGQING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap